Antonio Passaro: ETOP IBCSG Partners Foundation’s position statement on antibody-drug conjugates (ADC) in lung and breast cancer

Antonio Passaro, Lung cancer Oncologist and Researcher at IEO, recently shared on X:

“Just out in Annals of Oncology: ETOP IBCSG Partners Foundation’s position statement on antibody-drug conjugates (ADC) in lung and breast cancer.

Honored to be a part of it, diving into the current evidence and future directions for clinical ADC development.”

Read further.
Source: Antonio Passaro/X

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time, it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.